中国输血及用血领域临床实践指南/专家共识的方法学与报告质量评价

杨玉妹 ,  吴雨婷 ,  田雨 ,  丁伟峰 ,  王家莹 ,  杨蕾 ,  杜爱燕 ,  潘小枫 ,  李小杉 ,  高蓉 ,  王婷婷

中国输血杂志 ›› 2026, Vol. 39 ›› Issue (7) : 952 -962.

PDF (2165KB)
中国输血杂志 ›› 2026, Vol. 39 ›› Issue (7) : 952 -962. DOI: 10.13303/j.cjbt.issn.1004-549x.2026.07.021
循证输血医学

中国输血及用血领域临床实践指南/专家共识的方法学与报告质量评价

作者信息 +

Quality evaluation of methodological and reporting quality of clinical practice guidelines and expert consensuses on blood transfusion and blood utilization in china

Author information +
文章历史 +
PDF (2216K)

摘要

目的 评价中国输血及用血(BTBU)领域临床实践指南/专家共识的方法学与报告质量评价,为今后 BTBU 指南/共识的制定和更新提供参考。方法 系统检索中国知网、万方、维普数据库、PubMed、Web of Science 和相关指南发布平台、专业学会网站,纳入 2006 年 1 月至 2025 年 12 月间发布的 BTBU 相关指南/共识。依据纳排标准,完成文献筛选与数据提取后,由 3 名评价者独立采用指南科学性、透明性和适用性的评级工具(STAR)、指南研究与评价工具Ⅱ(AGREE Ⅱ)和国际实践指南报告规范(RIGHT),对纳入文献的质量进行评价。结果 共纳入 29 篇文献,其中指南 5 部,共识 22 部,方案 2 部。STAR 评价结果显示总分为(21.7±8.8)%,注册、计划书、资助、工作组、利益冲突、临床问题、证据、共识方法、推荐意见、可及性和其他领域的领域评分比例分别为(2.2±12.1)%、0、(36.7±25.1)%、(18.3±7.6)%、(19.2±15.3)%、(16.6±23.1)%、(15.1±6.3)%、(9.6±21.2)%、(54.3±18.4)%、(31.7±10.4)%和(10.3±31.0)%;AGREE Ⅱ评价结果显示 26 篇方法学质量为 B 级,3 篇为 C 级;RIGHT 评价结果显示,所有指南/共识的总体报告率为(65.3±4.0)%。结论 目前我国 BTBU 相关专家指南/共识的方法学和报告质量仍有待改进,应严格按照 STAR、AGREE Ⅱ和 RIGHT 的标准进行指南和共识的制定和规范。

Abstract

Objective To evaluate the methodological quality and reporting quality of clinical practice guidelines or expert consensus on blood transfusion and blood use (BTBU) in China(hereinafter referred to as "guidelines/consensus"), providing reference for the development and updating of future BTBU guidelines/consensus. Methods A systematic search was conducted in Chinese databases such as China National Knowledge Infrastructure(CNKI), Wanfang Data, VIP Database, relevant guideline release platforms, and professional association websites. BTBU-related guidelines/consensus published between January 2006 and December 2025 were included. According to the inclusion and exclusion criteria, after completing literature screening and data extraction, three evaluators independently assessed the quality of the included literature using the Scientificity, Transparency, and Applicability of Guidelines Rating Tool(STAR), the Appraisal of Guidelines for Research and Evaluation Ⅱ(AGREE Ⅱ), and the International Practice Guideline Reporting Standards(RIGHT). Results A total of 29 documents were included, including 5 guidelines, 22 consensus statements, and 2 protocols. The results of the STAR assessment showed that the total score was (21.7±8.8)%. The domain score ratios for registration, research protocol, funding, working group, conflict of interest, clinical question, evidence, consensus method, recommendation, accessibility and other domains were (2.2±12.1)%, 0, (36.7±25.1)%, (18.3±7.6)%, (19.2±15.3)%, (16.6±23.1)%, (15.1±6.3)%, (9.6±21.2)%, (54.3±18.4)%, (31.7±10.4)% and (10.3±31.0)%, respectively. For the AGREE Ⅱ assessment, the methodological quality of 26 articles was rated Grade B and 3 articles Grade C. The results of the RIGHT assessment indicated that the overall reporting rate of all guidelines/consensuses was (65.3±4.0)%. Conclusion The methodological and reporting quality of current expert guidelines/consensus on BTBU in China still need improvement, and guidelines and consensus should be strictly formulated and standardized according to the standards of STAR, AGREE II and RIGHT.

关键词

输血及用血 / 临床实践指南 / 专家共识 / STAR / AGREE Ⅱ / RIGHT

Key words

blood transfusion and blood use(BTBU) / clinical practice guidelines / expert consensus / STAR / AGREE Ⅱ / RIGHT

引用本文

引用格式 ▾
杨玉妹,吴雨婷,田雨,丁伟峰,王家莹,杨蕾,杜爱燕,潘小枫,李小杉,高蓉,王婷婷. 中国输血及用血领域临床实践指南/专家共识的方法学与报告质量评价[J]. 中国输血杂志, 2026, 39(7): 952-962 DOI:10.13303/j.cjbt.issn.1004-549x.2026.07.021

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

DREBES A, DEVOS M, GILL S, et al. Prothrombin complex concentrates for coagulopathy in liver disease: single-center, clinical experience in 105 patients[J].Hepatol Commun, 2019, 3(4):513-524.

[2]

FOUKANELI T, KERR P, BOLTON-MAGGS P H B, et al. Guidelines on the use of irradiated blood components[J].Br J Haematol, 2020, 191(5):704-724.

[3]

LEEYT, TANYER, OONCE. Molecular targeted therapy:treating cancer with specificity[J].Eur J Pharmacol, 2018, 834(6):188-196.

[4]

GAGLIARDI A R, MARSHALL C, HUCKSON S, et al. Developing a checklist for guideline implementation planning:review and synthesis of guideline development and implementation advice[J].Implement Sci, 2015, 10:19.

[5]

CHEN Y, YANG K, MARUŠIC A, et al. A reporting tool for practice guidelines in health care: the RIGHT statement[J].Ann Intern Med, 2017, 166(2):128-132.

[6]

BROUWERS M C, KERKVLIET K, SPITHOFF K. The AGREE reporting checklist:a tool to improve reporting of clinical practice guidelines[J].BMJ, 2016, 352:152.

[7]

李志强,宫济武,魏晴. 2019 新型冠状病毒肺炎防控期间临床输血血型血清学实验室生物安全防护指南(第二版)[J].临床输血与检验, 2020, 22(3):225-228.

[8]

LI Z Q, GONG J W, WEI Q. Guidelines for biosafety protection of blood group serology laboratories in clinical transfusion during COVID-19 prevention and control(2nd edition)[J].J Clin Transfus Lab Med, 2020, 22(3):225-228.

[9]

钱宝华,顾海慧,查占山. 创伤紧急救治通用型红细胞输注专家共识[J].中国输血杂志, 2017, 30(7):668-669.

[10]

QIAN B H, GU H H, ZHA Z S. Expert consensus on universal red blood cell transfusion for emergency trauma treatment[J].Chin J Blood Transfusion, 2017, 30(7):668-669.

[11]

大量输血现状调研协作组,杨江存,徐永刚,等. 量输血指导方案(推荐稿)[J].中国输血杂志, 2012, 25(7):617-621.

[12]

INVESTIGATION GROUP FOR MASSIVE TRANSFUSION STATUS, YANG J C, XU Y G, et al. Recommended guidelines for massive transfusion[J].Chin J Blood Transfusion, 2012, 25(7):617-621.

[13]

中华医学会临床输血学分会,中国医师协会输血科医师分会. 特殊情况紧急抢救输血推荐方案[J].中国输血杂志, 2014, 27(1):1-3.

[14]

CHINESE SOCIETY OF CLINICAL TRANSFUSION MEDICINE, CHINESE MEDICAL DOCTOR ASSOCIATION BRANCH OF BLOOD TRANSFUSION PHYSICIANS. Recommended Scheme for Emergency Blood Transfusion in Special Circumstances[J].Chinese Journal of Blood Transfusion, 2014, 27(1):1-3.

[15]

中国输血协会临床输血学专业委员会《血液成分输注临床路径》制订协作组. 血液成分输注临床路径专家共识(2018 年)[J].临床血液学杂志, 2018, 31(2):81-84.

[16]

WORKING GROUP FOR CLINICAL PATHWAY OF BLOOD COMPONENT TRANSFUSION, CLINICAL TRANSFUSION COMMITTEE OF CSBT. Expert consensus on clinical pathways of blood component transfusion (2018)[J].J Clin Hematol, 2018, 31(2):81-84.

[17]

中国输血协会临床输血专业委员会. 自体输血临床路径管理专家共识(2019)[J].临床血液学杂志, 2019, 32(2):81-86.

[18]

CLINICAL TRANSFUSION COMMITTEE OF CSBT. Expert consensus on clinical pathway management of autologous blood transfusion (2019)[J].J Clin Hematol, 2019, 32(2):81-86.

[19]

田玉科. 围术期输血指南[J].中国继续医学教育, 2011, 3(10):124-128.

[20]

TIAN Y K. Guidelines for perioperative blood transfusion[J].China Contin Med Educ, 2011, 3(10):124-128.

[21]

朱长太,侯琦,高宗帅,等. 社会医疗机构临床用血管理专家共识[J].中国卫生质量管理, 2025, 32(3):83-87,91.

[22]

ZHU C T, HOU Q, GAO Z S, et al. Expert consensus on clinical blood use management in social medical institutions[J].Chin Health Qual Manag, 2025, 32(3):83-87,91.

[23]

周吉成,于洋,夏荣,等. 输血相关急性肺损伤诊治中国专家共识(2023 版)[J].临床输血与检验, 2023, 25(5):577-585.

[24]

ZHOU J C, YU Y, XIA R, et al. Chinese expert consensus on diagnosis and treatment of transfusion-related acute lung injury (2023 edition)[J].J Clin Transfus Lab Med, 2023, 25(5):577-585.

[25]

邵超鹏,骆群,伍昌林. 输血依赖型地中海贫血(TDT)患者临床输血中国专家共识[J].临床输血与检验, 2023, 25(2):163-169.

[26]

SHAO C P, LUO Q, WU C L. Chinese expert consensus on clinical transfusion for patients with transfusion-dependent thalassemia[J].J Clin Transfus Lab Med, 2023, 25(2):163-169.

[27]

伊文. 特殊情况紧急输血专家共识[J].健康管理, 2015(2):82-85.

[28]

YI W. Expert consensus on emergency blood transfusion in special situations[J].Health Manag, 2015(2):82-85.

[29]

伍利利,张印则. 医疗机构临床用血技术规范深圳专家共识[J].中国输血杂志, 2024, 37(11):1213-1220,1233.

[30]

WU L L, ZHANG Y Z. Shenzhen expert consensus on technical specifications for clinical blood use in medical institutions[J].Chin J Blood Transfusion, 2024, 37(11):1213-1220,1233.

[31]

苑召虎,张印则. 异基因造血干细胞移植临床输血专家共识[J].临床输血与检验, 2023, 25(5):586-593.

[32]

YUAN Z H, ZHANG Y Z. Expert consensus on clinical blood transfusion for allogeneic hematopoietic stem cell transplantation[J].J Clin Transfus Lab Med, 2023, 25(5):586-593.

[33]

黄俊彬,温建芸,陈艳. 中国儿童输血依赖型地中海贫血输血管理指南(2025 年)[J].中国当代儿科杂志, 2025, 27(5):505-514.

[34]

HUANG J B, WEN J Y, CHEN Y. Chinese guidelines for transfusion management of children with transfusion-dependent thalassemia(2025)[J].Chin J Contemp Pediatr, 2025, 27(5):505-514.

[35]

李志强. 重型和危重型 COVID-19 患者血液成分安全输注专家共识[J].临床输血与检验, 2023, 25(2):149-162.

[36]

LI Z Q. Expert consensus on safe transfusion of blood components in severe and critical COVID-19 patients[J].J Clin Transfus Lab Med, 2023, 25(2):149-162.

[37]

杜磊,周成斌,吉冰洋,等. 成人心血管外科手术体外循环患者血液管理指南[J].中国临床胸心血管外科杂志, 2024, 31(11):1547-1559.

[38]

DU L, ZHOU C B, JI B Y, et al. Guidelines for patient blood management during cardiopulmonary bypass in adult cardiovascular surgery[J].Chin J Clin Thorac Cardiovasc Surg, 2024, 31(11):1547-1559.

[39]

崔广霞,陈麟凤,白文佩,等. 妇科恶性肿瘤围术期患者血液管理专家共识(2025 年版)[J].中国实用妇科与产科杂志, 2025, 41(3):316-323.

[40]

CUI G X, CHEN L F, BAI W P, et al. Expert consensus on perioperative patient blood management for gynecological malignancies(2025 edition)[J].Chin J Pract Gynecol Obstet, 2025, 41(3):316-323.

[41]

医疗机构患者血液管理标准化实施专家共识编写组,李颖川,夏家红,等. 医疗机构患者血液管理标准化实施专家共识[J].中国卫生质量管理, 2025, 32(12):76-81.

[42]

WRITING GROUP FOR EXPERT CONSENSUS ON STANDARDIZED IMPLEMENTATION OF PATIENT BLOOD MANAGEMENT, LI Y C, XIA J H, et al. Expert consensus on standardized implementation of patient blood management in medical institutions[J].Chin Health Qual Manag, 2025, 32(12):76-81.

[43]

敬承旺,古育玲,周晓露. 成人原发免疫性血小板减少症患者血液管理专家共识(2024 版)[J].中国实用内科杂志, 2024, 44(10):827-833.

[44]

JING C W, GU Y L, ZHOU X L. Expert consensus on patient blood management for adults with primary immune thrombocytopenia(2024 edition)[J].Chin J Pract Intern Med, 2024, 44(10):827-833.

[45]

杨欣,魏丽惠. 妇科围手术期患者血液管理专家共识(2024 版)[J].中国临床妇产科杂志, 2024, 25(4):380-384.

[46]

YANG X, WEI L H. Expert consensus on perioperative patient blood management in gynecology(2024 edition)[J].Chin J Clin Obstet Gynecol, 2024, 25(4):380-384.

[47]

李云龙,娄世峰,张曦. 成人缺铁性贫血患者血液管理专家共识[J].检验医学与临床, 2023, 20(18):2625-2632,2637.

[48]

LI Y L, LOU S F, ZHANG X. Expert consensus on patient blood management for adults with iron deficiency anemia[J].Lab Med Clin, 2023, 20(18):2625-2632,2637.

[49]

周吉成,胡丽华. 非心脏外科围手术期患者血液管理专家共识(2022 版)[J].临床输血与检验, 2022, 24(5):545-553.

[50]

ZHOU J C, HU L H. Expert consensus on perioperative patient blood management for non-cardiac surgery(2022 edition)[J].J Clin Transfus Lab Med, 2022, 24(5):545-553.

[51]

周吉成,胡丽华,马现君,等. 创伤性出血患者血液管理专家共识(2022 年版)[J].中国临床新医学, 2022, 15(6):469-476.

[52]

ZHOU J C, HU L H, MA X J, et al. Expert consensus on patient blood management for traumatic hemorrhage (2022 edition)[J].Chin J New Clin Med, 2022, 15(6):469-476.

[53]

周吉成,胡丽华,王宝燕,等. 产后出血患者血液管理专家共识(2022 年版)[J].中国临床新医学, 2022, 15(1):1-5.

[54]

ZHOU J C, HU L H, WANG B Y, et al. Expert consensus on patient blood management for postpartum hemorrhage(2022 edition)[J].Chin J New Clin Med, 2022, 15(1):1-5.

[55]

胡丽华,周吉成,谢珏. 外科 ICU 患者血液管理专家共识(2021 版)[J].中华危重症医学杂志(电子版), 2021, 14(4):265-268.

[56]

HU L H, ZHOU J C, XIE J. Expert consensus on patient blood management in surgical ICU(2021 edition)[J].Chin J Crit Care Med (Electron Ed), 2021, 14(4):265-268.

[57]

胡盛寿,纪宏文,孙寒松,等. 心血管手术患者血液管理专家共识[J].中国输血杂志, 2018, 31(4):321-325.

[58]

HU S S, JI H W, SUN H S, et al. Expert consensus on patient blood management for cardiovascular surgery[J].Chin J Blood Transfusion, 2018, 31(4):321-325.

[59]

杨欣,李艺,狄文,等. 妇科围手术期患者血液管理的专家共识[J].中国临床妇产科杂志, 2019, 20(6):560-563.

[60]

YANG X, LI Y, DI W, et al. Expert consensus on perioperative patient blood management in gynecology[J].Chin J Clin Obstet Gynecol, 2019, 20(6):560-563.

[61]

中国输血协会临床输血学专业委员会. 内科重症监护病房的患者血液管理专家共识[J].临床血液学杂志, 2020, 33(2):83-86.

[62]

CLINICAL TRANSFUSION COMMITTEE OF CSBT. Expert consensus on patient blood management in medical intensive care unit[J].J Clin Hematol, 2020, 33(2):83-86.

[63]

YAN S, ZHOU L, CHEN C, et al. 2024 guidelines on patient blood management for adult cardiac surgery under cardiopulmonary bypass in China[J].Rev Cardiovasc Med, 2025, 26(6):31384.

[64]

杨楠,赵巍,潘旸,等. 针对临床实践指南科学性、透明性和适用性的评级工具研发[J].中华医学杂志, 2022, 102(30):2329-2337.

[65]

YANG N, ZHAO W, PAN Y, et al. Development of rating tool for scientificity, transparency and applicability of clinical practice guidelines[J].Natl Med J China, 2022, 102(30):2329-2337.

[66]

Star 疼痛学专业委员会. 如何提高疼痛学科专家共识和指南的质量与等级[J].中国疼痛医学杂志, 2023, 19(4):529-530.

[67]

PAIN COMMITTEE OF STAR ASSOCIATION. Strategies to improve quality and grade of expert consensuses and guidelines in pain discipline[J].Chin J Pain, 2023, 19(4):529-530.

[68]

陈耀龙,孙雅佳,罗旭飞,等. 循证医学的核心方法与主要模型[J].北京协和医学院学报, 2023, 14(1):1-8.

[69]

CHEN Y L, SUN Y J, LUO X F, et al. Core methods and main models of evidence-based medicine[J].Med J Peking Union Med Coll, 2023, 14(1):1-8.

[70]

陈耀龙,刘辉,姚志荣,等. 提升皮肤病领域指南和共识质量的策略与建议[J].中华皮肤科杂志, 2023, 56(9):805-808.

[71]

CHEN Y L, LIU H, YAO Z R, et al. Strategies and suggestions for improving the quality of guidelines and consensuses in dermatology[J].Chin J Dermatol, 2023, 56(9):805-808.

[72]

邓辉,王梦琪,孟祥然,等. 基于 AGREEⅡ及 RIGHT 的儿童孤独症诊疗指南/共识质量评价研究[J].解放军医学杂志, 2024, 49(9):977-985.

[73]

DENG H, WANG M Q, MENG X R. Quality evaluation of guidelines/consensuses for diagnosis and treatment of childhood autism based on AGREE Ⅱ and RIGHT[J].Med J Chin PLA, 2024, 49(9):977-985.

[74]

吕晗,王悍,刘军,等. 提升指南及共识质量,促进影像医学高质量发展[J].放射学实践, 2025, 40(2):137-140.

[75]

LYU H, WANG H, LIU J. Improve the quality of guidelines and consensuses to promote high-quality development of imaging medicine[J].Radiol Pract, 2025, 40(2):137-140.

[76]

WORLD HEALTH ORGANIZATION. WHO handbook for guideline development:supplement:criteria for use of evidence to inform recommendations in World Health Organization guidelines[M/OL].(2023-08-14)[2025-11-02].https://www.who.int/publications/i/item/WHO-SCI-QNS-MST-2023.1

[77]

WORLD HEALTH ORGANIZATION. WHO handbook for guideline development, 2nd ed[M/OL].(2014-12-18)[2025-11-02].https://www.who.int/publications/i/item/9789241548960

基金资助

国家科技重大专项(2023ZD0505900)

无锡市人民医院 2025“雁阵人才”学科带头人-2025(YZ-XKDTR-WTT-2025)

无锡市人民医院 2025“雁阵人才”青年拔尖人才项目(2025-YZ-QNBJ-GR-2025)

AI Summary AI Mindmap
PDF (2165KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉